You are here

AbbVie to build US$320m manufacturing facility here

[SINGAPORE] US pharmaceutical firm AbbVie will invest US$320 million to build a manufacturing facility here. It will be the company's first manufacturing facility in Asia, and is expected to be fully operational by 2019.

AbbVie, formed in 2013 after its separation from Abbott Laboratories

Market voices on:

Powered by GET.comGetCom